Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biocult Plus is a probiotic nutraceutical supplement developed by Homeosyn Italia and distributed by Italfarmacia. It is designed to support intestinal flora balance and overall gastrointestinal health. The formulation includes a blend of probiotic bacterial strains—Lactobacillus bulgaricus, Bifidobacterium longum, Lactobacillus casei, and Lactobacillus acidophilus—along with the prebiotic fiber inulin, which promotes the growth of beneficial gut bacteria. The supplement is further enriched with a comprehensive vitamin complex, including B-group vitamins (B1, B2, B3, B5, B6), folic acid, biotin, vitamin C, and vitamin E, to support energy metabolism, immune function, and antioxidant protection. It is typically used to address intestinal dysbiosis, bloating, and nutrient deficiencies, particularly following antibiotic treatment. While often distributed in sachet form, it is also available in oral tablet or capsule formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biocult Plus.